Insulin secretion and sensitivity in the prediction of type 1 diabetes in children with advanced b-cell autoimmunity

European Journal of Endocrinology

Volumn 169, Issue 4, 2013, Pages 479-485

  Siljander, Heli T ^a,b,c   Hermann, Robert ^d   Hekkala, Anne ^e   Lahde, Jyrki ^c   Tanner, Laura ^d   Keskinen, Paivi ^c   Ilonen, Jorma ^d,f   Simell, Olli ^d   Veijola, Riitta ^e   Knip, Mikael ^a,b,c  

^a UNIVERSITY OF HELSINKI AND HELSINKI UNIVERSITY HOSPITAL   (Finland)

^b UNIVERSITY OF HELSINKI   (Finland)

^c TAMPERE UNIVERSITY HOSPITAL   (Finland)

^d UNIVERSITY OF TURKU   (Finland)

^e UNIVERSITY OF OULU   (Finland)

^f UNIVERSITY OF EASTERN FINLAND   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

INSULIN ANTIBODY; ISLET ANTIGEN 2 ANTIBODY; PANCREAS ISLET CELL ANTIBODY; UNCLASSIFIED DRUG;

ADOLESCENT; AGE; ARTICLE; AUTOIMMUNITY; BODY MASS; CHILD; CLINICAL ASSESSMENT TOOL; CONTROLLED STUDY; DISEASE COURSE; DISEASE MARKER; DISEASE PREDISPOSITION; FEMALE; FIRST PHASE INSULIN RESPONSE; GENE; GENETIC SUSCEPTIBILITY; HLA DQB1 GENE; HOMEOSTASIS MODEL ASSESSMENT INDEX FOR INSULIN RESISTANCE; HUMAN; HUMORAL IMMUNITY; IMPAIRED GLUCOSE TOLERANCE; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN RELEASE; INSULIN RESISTANCE; INSULIN RESPONSE; INSULIN SENSITIVITY; INTRAVENOUS GLUCOSE TOLERANCE TEST; MAJOR CLINICAL STUDY; MALE; PREDICTION; PREDICTIVE VALUE; PRESCHOOL CHILD; PRIORITY JOURNAL; PROGNOSIS; RISK FACTOR; SCHOOL CHILD; SEROCONVERSION;

ADOLESCENT; AUTOANTIBODIES; AUTOIMMUNITY; CHILD; CHILD, PRESCHOOL; DIABETES MELLITUS, TYPE 1; DISEASE PROGRESSION; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GLUCOSE TOLERANCE TEST; HLA-DQ BETA-CHAINS; HUMANS; INFANT; INSULIN; INSULIN ANTIBODIES; INSULIN RESISTANCE; INSULIN-SECRETING CELLS; MALE; PREDIABETIC STATE; PREDICTIVE VALUE OF TESTS; RISK FACTORS;

EID: 84884843801     PISSN: 08044643     EISSN: 1479683X     Source Type: Journal    
DOI: 10.1530/EJE-13-0206     Document Type: Article

References (24)

1. Bingley PJ. Interactions of age, islet cell antibodies, insulin autoantibodies, and first-phase insulin response in predicting risk of progression to IDDM in ICAC relatives: the ICARUS data set. Islet Cell Antibody Register Users Study. Diabetes 1996 45 1720-1728. (doi:10.2337/diabetes.45.12. 1720) (Pubitemid 26398951)
2. Mrena S, Virtanen SM, Laippala P, Kulmala P, Hannila ML, A kerblom HK & Knip M. Models for predicting type 1 diabetes in siblings of affected children. Diabetes Care 2006 29 662-667. (doi:10.2337/diacare.29.03.06.dc05- 0774) (Pubitemid 44115370)
3. Siljander HT, Simell S, Hekkala A, Lahde J, Simell T, Vahasalo P, Veijola R, Ilonen J, Simell O & Knip M. Predictive characteristics of diabetes-associated autoantibodies among children with HLAconferred disease susceptibility in the general population. Diabetes 2009 58 2835-2842. (doi:10.2337/db08-1305)
4. Xu P, Wu Y, Zhu Y, Dagne G, Johnson G, Cuthbertson D, Krischer JP, Sosenko JM, Skyler JS & Diabetes Prevention Trial-Type 1 (DPT-1) Study Group . Prognostic performance of metabolic indexes in predicting onset of type 1 diabetes. Diabetes Care 2010 33 2508-2513. (doi:10.2337/dc10-0802)
5. Daniel S, Noda M, Straub SG & Sharp GWG. Identification of the docked granule pool responsible for the first phase of glucosestimulated insulin secretion. Diabetes 1999 48 1-5. (doi:10.2337/diabetes.48.9.1686)
6. Veijola R, Vahasalo P, Tuomilehto-Wolf E, Reijonen H, Kulmala P, Ilonen J, Akerblom HK & Knip M. Human leukocyte antigen identity and DQ risk alleles in autoantibody-positive siblings of children with IDDM are associated with reduced early insulin response. Diabetes 1995 44 1021-1028. (doi:10.2337/diabetes. 44.9.1021)
7. Keskinen P, Korhonen S, Kupila A, Veijola R, Erkkila S, Savolainen H, Arvilommi P, Simell T, Ilonen J, Knip M et al. Firstphase insulin response in young healthy children at genetic and immunological risk for type I diabetes. Diabetologia 2002 45 1639-1648. (doi:10.1007/s00125-002-0981-8) (Pubitemid 35478133)
8. Fourlanos S, Narendran P, Byrnes GB, Colman PG & Harrison LC. Insulin resistance is a risk factor for progression to type 1 diabetes. Diabetologia 2004 47 1661-1667. (doi:10.1007/s00125-004-1507-3) (Pubitemid 40022398)
9. Xu P, Cuthbertson D, Greenbaum C, Palmer JP, Krischer JP & Diabetes Prevention Trial-Type 1 Study Group. Role of insulin resistance in predicting progression to type 1 diabetes. Diabetes Care 2007 30 2314-2320. (doi:10.2337/dc06-2389) (Pubitemid 47359040)
10. Wilkin TJ. The accelerator hypothesis: weight gain as the missing link between type I and type II diabetes. Diabetologia 2001 44 914-922. (doi:10.1007/s001250100548) (Pubitemid 32642465)
11. Ilonen J, Reijonen H, Herva E, Sjoroos M, Iitia A, Lovgren T, Veijola R, Knip M & A kerblom HK. Rapid HLA-DQB1 genotyping for four alleles in the assessment of risk for IDDM in the Finnish population. The Childhood Diabetes in Finland (DiMe) Study Group. Diabetes Care 1996 19 795-800. (doi:10.2337/ diacare. 19.8.795) (Pubitemid 26286981)
12. Hekkala A, Ilonen J, Knip M, Veijola R & Finnish Paediatric Diabetes Register. Family history of diabetes and distribution of class II HLA genotypes in children with newly diagnosed type 1 diabetes: effect on diabetic ketoacidosis. European Journal of Endocrinology 2011 165 813-817. (doi:10.1530/EJE-11-0376)
13. Nanto-Salonen K, Kupila A, Simell S, Siljander H, Salonsaari T, Hekkala A, Korhonen S, Erkkola R, Sipila J, Haavisto L et al. Nasal insulin in prevention of type 1 diabetes in autoantibody-positive children with HLA-conferred disease susceptibility and recruited from the general population. Lancet 2008 372 1746-1755. (doi:10.1016/S0140-6736(08)61309-4)
14. World Health Organization. Definition, Diagnosis, and Classification of Diabetes Mellitus and its Complications: Report of a WHO Consultation. In World Health Organization publications, pp 66. Geneva, World Health Organization, 1999.
15. Parkkola A, Harkonen T, Ryhanen SJ, Ilonen J, Knip M & Finnish Pediatric Diabetes Register. Extended family history of type 1 diabetes and phenotype and genotype of newly diagnosed children. Diabetes Care 2013 36 348-354. (doi:10.2337/dc12-0445)
16. Beach EF & Turner JJ. An enzymatic method for glucose determination in body fluids. Clinical Chemistry 1958 4 462-475.
17. Andersen L, Dinesen B, Jørgensen PN, Poulsen F & Røder M. Enzyme immunoassay for intact human insulin in serum and plasma. Clinical Chemistry 1993 39 578-582. (Pubitemid 23118305)
18. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF & Turner RC. Homeostasis model assessment: insulin resistance and b-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985 28 412-419. (doi:10.1007/BF00280883) (Pubitemid 15018832)
19. WHO Multicentre Growth Reference Study Group. WHO Child Growth Standards: Length/height-for-age, weight-for-age, weightfor-length,weight-for-height and body mass index-for-age:Methods and development. In World Health Organization publications, pp 312. Web site: http://www.who.int/childgrowth/publications/en. Geneva: World Health Organization, 2006.
20. De Onis M, Onyango A, Borghi E, Siyam A, Nishida C & Siekmann J. Development of a WHO growth reference for school-aged children and adolescents. Bulletin of the World Health Organization 2007 85 661-668. (doi:10.2471/BLT.07. 043497)
21. Hermann R, Lipponen K, Kiviniemi M, Kakko T, Veijola R, Simell O, Knip M & Ilonen J. Lymphoid tyrosine phosphatase (LYP/PTPN22) Arg620Trp variant regulates insulin autoimmunity and progression to type 1 diabetes. Diabetologia 2006 49 1198-1208. (doi:10.1007/s00125-006-0225-4)
22. Hermann R, Laine AP, Veijola R, Vahlberg T, Simell S, Lahde J, Simell O, Knip M & Ilonen J. The effect of HLA class II, insulin and CTLA4 gene regions on the development of humoral b cell autoimmunity. Diabetologia 2005 48 1766-1775. (doi:10.1007/s00125-005-1844-x) (Pubitemid 41317830)
23. Hawa MI, Bonfanti R, Valeri C, Delli Castelli M, Beyan H & Leslie RDG. No evidence for genetically determined alteration in insulin secretion or sensitivity predisposing to type 1 diabetes: a study of identical twins. Diabetes Care 2005 28 1415-1418. (doi:10.2337/diacare.28.6.1415) (Pubitemid 40756706)
24. Bingley PJ, Mahon JL, Gale EA & the European Nicotinamide Diabetes Intervention Trial (ENDIT) Group. Insulin resistance and progression to type 1 diabetes in the European Nicotinamide Diabetes Intervention Trial (ENDIT). Diabetes Care 2008 31 146-150. (doi:10.2337/dc07-0103)